CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand

  • ID: 3993829
  • Report
  • Region: Thailand
  • 229 pages
  • GlobalData
1 of 4
Medical Tourism will Drive Thailand’s Pharmaceutical Market Towards $9.5 Billion by 2020
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand

Summary

The author, who is an industry analysis specialist, has released their latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.

Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.

In 2015, the population of Thailand 68.84 million, and it is estimated to reach 69.31 million by 2020. The value of the pharmaceutical market was estimated at $5.91 billion in 2015, and is expected to reach $9.47 billion in 2020, increasing at a projected CAGR of 10%.

The positive trends in the healthcare market of Thailand can be attributed primarily to:

- Increasing medical tourism
- Increasing health awareness
- Greater access to life-saving facilities

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes -
- An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline (GSK), Sanofi, Roche, AstraZeneca and Novartis.
- An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices
- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures
- An overview of the opportunities and challenges for growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

- Develop business strategies by understanding the trends shaping and driving Thailand’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Thailand’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Report Guidance

3 Overview of Pharmaceutical and Medical Device Markets

3.1 Pharmaceutical Market

3.1.1 Market Overview

3.1.2 Pharmaceutical Import and Export

3.1.3 Supply Channels

3.1.4 Market Segments

3.1.5 Major Therapeutic Areas

3.1.6 Major Companies

3.2 Medical Device Market

3.2.1 Market Overview

3.3 Market Drivers and Barriers

3.3.1 Drivers

3.3.2 Barriers

4 Market Access

4.1 Reimbursement and Payer Landscape

4.1.1 Overview of Healthcare system

4.1.2 Reimbursement Process

4.1.3 Overview of Insurance Providers

4.1.4 Patient Share in Healthcare Spending

4.1.5 Price Trends in the Healthcare Sector

4.1.6 Pricing Policies

4.2 Regulatory Landscape

4.2.1 Overview of Regulatory Agencies

4.2.2 Market Authorization Procedure for Pharmaceutical Products

4.2.3 New Medical Device Approval Process

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.2.5 Licensing Process for Pharmaceutical Exports and Imports

4.2.6 Intellectual Property Rights

4.2.7 Clinical Trial Regulations

4.2.8 Pharmaceutical Advertising Regulations

4.2.9 Pharmacy Regulations

4.2.10 Labelling and Packaging Regulations

5 Country Analysis

5.1 Political Environment

5.1.1 Political Structure

5.1.2 Analysis of the Current Political Environment

5.1.3 Healthcare Policy Initiatives

5.2 Economic Landscape

5.3 Economic Indicators

5.3.1 Gross Domestic Product

5.3.2 Gross National Income

5.3.3 Inflation

5.3.4 Currency Exchange Rate

5.3.5 Foreign Direct Investment

5.3.6 Foreign Exchange Reserves

5.3.7 Trade Balance

5.3.8 Government Structural Balance

5.3.9 Government Net Debt

5.3.10 Major Industries

5.4 Demographics

5.4.1 Population

5.4.2 Education and Literacy

5.4.3 Employment

5.4.4 Disease Burden

5.5 Healthcare Infrastructure

5.5.1 Healthcare Facilities

5.5.2 Healthcare Parameters

5.5.3 Environmental Health

5.5.4 Healthcare Personnel

5.6 Healthcare Expenditure

5.6.1 Overview of Healthcare Expenditure

5.6.2 Major Components of Healthcare Expenditure

5.6.3 Healthcare Expenditure Distribution

5.6.4 Spending in Pharmaceutical R&D

5.7 Trade Associations

5.7.1 Thai Pharmaceutical Manufacturers Association

5.7.2 Thai Medical Technology Industry Association

5.7.3 Thai Self-Medication Industry Association

5.7.4 The Medical Association of Thailand

5.8 Trade Fairs

6 Opportunities and Challenges

6.1 Opportunities

6.2 Challenges

7 Appendix

7.1 Abbreviations

7.2 Bibliography

7.3 Research Methodology

7.3.1 Coverage

7.3.2 Secondary Research

7.3.3 Forecasts

7.3.4 Expert Panel

7.4 Disclaimer

1.1 List of Tables

Table 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008-2015

Table 2: Pharmaceutical Market, Thailand, Revenue ($bn), 2016-2020

Table 3: Pharmaceutical Imports and Exports, Thailand, Revenue ($bn), 2008-2015

Table 4: Pharmaceutical Market, Thailand, Pharmaceutical Product Sales by Segment (%), 2015

Table 5: Major Therapeutic Areas, Thailand, Prevalence (%), 2010

Table 6: Major Products, GSK, Global, 2015

Table 7: Late-Stage Pipeline, GSK, Global, 2015

Table 8: Major Products, Sanofi, Global, 2015

Table 9: Late-Stage Pipeline, Sanofi, Global, 2015

Table 10: Major Products, Roche, Global, 2015

Table 11: Late-Stage Pipeline, Roche, Global, 2016

Table 12: Major Products, AstraZeneca, Global, 2016

Table 13: Planned Filings, AstraZeneca, Global, 2016

Table 14: Major Products, Novartis, Global, 2016

Table 15: Late-Stage Pipeline, Novartis, Global, 2015

Table 16: Medical Device Market, Thailand, Revenue ($bn), 2008-2015

Table 17: Medical Device Market, Thailand, Revenue ($bn), 2016-2020

Table 18: Public Health Insurance Schemes, Thailand, 2016

Table 19: Health Benefits Coverage, Thailand, 2011

Table 20: Market Access, Thailand, Patient Share of Total Health Expenditure (%), 2008-2015

Table 21: Market Access, Thailand, Producer Price Change (%), 2008-2015

Table 22: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2008-2015

Table 23: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2016-2020

Table 24: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2008-2015

Table 25: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2016-2020

Table 26: Economic Indicators, Thailand, Gross National Income per Capita ($), 2008-2014

Table 27: Economic Indicators, Thailand, Consumer Price Index, 2008-2015

Table 28: Economic Indicators, Thailand, Consumer Price Index, 2016-2020

Table 29: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2008-2015

Table 30: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2016-2020

Table 31: Economic Indicators, Thailand, Currency Exchange Rate (THB/$), 2008-2015

Table 32: Economic Indicators, Thailand, Foreign Direct Investment ($bn), 2008-2014

Table 33: Economic Indicators, Thailand, Foreign Exchange Reserves ($bn), 2008-2014

Table 34: Economic Indicators, Thailand, Imports of Goods and Services ($bn), 2008-2014

Table 35: Economic Indicators, Thailand, Exports of Goods and Services ($bn), 2008-2014

Table 36: Economic Indicators, Thailand, Government Structural Balance ($bn), 2008-2015

Table 37: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2008-2015

Table 38: Economic Indicators, Thailand, General Government Net Debt, (% of GDP), 2016-2020

Table 39: Major Industries, Thailand, Share of GDP at Current Market Prices (%), 2014

Table 40: Demographics, Thailand, Population (million), 2008-2015

Table 41: Demographics, Thailand, Population (million), 2016-2020

Table 42: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2008-2015

Table 43: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2016-2020

Table 44: Demographics, Thailand, Population Distribution (%), 2008-2015

Table 45: Demographics, Thailand, Population Distribution (%), 2016-2020

Table 46: Demographics, Thailand, Births (per 1,000 population), 2008-2015

Table 47: Demographics, Thailand, Mortality (per 1,000 population), 2008-2015

Table 48: Demographics, Major Causes of Mortality, Thailand, Share of Total Mortality (%), 2014

Table 49: Demographics, Thailand, Children Under Five Years of Age, Mortality (per 1,000 live births), 2008-2015

Table 50: Demographics, Thailand, Immunization Rate (%), 2008-2015

Table 51: Demographics, Thailand, Major Causes of Male Mortality (Share %), 2010

Table 52: Demographics, Thailand, Major Causes of Female Mortality (Share%), 2010

Table 53: Demographics, Thailand, Gender Ratio (M/F), 2008-2015

Table 54: Demographics, Thailand, Life Expectancy at Birth (years), 2008-2015

Table 55: Demographics, Thailand, Life Expectancy at Birth (Years), 2016-2020

Table 56: Demographics, Thailand, Gross Enrolment Ratio (%), 2008-2015

Table 57: Demographics, Thailand, Unemployment Rate (%), 2008-2015

Table 58: Demographics, Thailand, Major Diseases, DALYs, 2012

Table 59: Healthcare Infrastructure, Thailand, Hospitals, 2008-2015

Table 60: Healthcare Infrastructure, Thailand, Public and Private Hospitals, 2008-2015

Table 61: Healthcare Infrastructure, Thailand, Hospitals by Standard of Care, Share (%), 2010

Table 62: Healthcare Infrastructure, Thailand, Hospital Beds by Authority and Region, Share (%), 2010

Table 63: Healthcare Infrastructure, Thailand, Hospital Beds (per 1,000 population), 2008-2015

Table 64: Healthcare Infrastructure, Thailand, Doctors (per 1,000 Population), 2008-2015

Table 65: Healthcare Infrastructure, Thailand, PM2.5 emissions (µgm/m³), 2008-2015

Table 66: Healthcare Infrastructure, Thailand, CO2 Emissions (Metric Tons Per Capita), 2008-2015

Table 67: Healthcare Infrastructure, Thailand, Dentists (per 100,000 population), 2008-2015

Table 68: Healthcare Infrastructure, Thailand, Nurses (per 100,000 population), 2008-2015

Table 69: Healthcare Infrastructure, Thailand, Pharmacists (per 100,000 population), 2008-2015

Table 70: Healthcare Expenditure (% of GDP), Thailand, 2008-2015

Table 71: Healthcare Expenditure, Thailand, Major Components of Healthcare Expenditure (%), 2012

Table 72: Healthcare Expenditure, Thailand, Public and Private Shares of GDP (%), 2008-2015

Table 73: Healthcare Expenditure, Thailand, R&D Expenditure (% of GDP), 2008-2015

Table 74: Healthcare Expenditure, Thailand, Major Healthcare Trade Fairs, 2017

1.2 List of Figures

Figure 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008-2015

Figure 2: Pharmaceutical Market, Thailand, Revenue ($bn), 2016-2020

Figure 3: Pharmaceutical Imports and Exports, Thailand, Revenue ($bn), 2008-2015

Figure 4: Pharmaceutical Industry, Thailand, Structure, 2016

Figure 5: Pharmaceutical Market, Thailand, Pharmaceutical Product Sales by Segment (%), 2015

Figure 6: Major Therapeutic Areas, Thailand, Prevalence (%), 2010

Figure 7: Medical Device Market, Thailand, Revenue ($bn), 2008-2015

Figure 8: Medical Device Market, Thailand, Revenue ($bn), 2016-2020

Figure 9: Drivers and Barriers, Healthcare Market, Thailand, 2016

Figure 10: Reimbursement Fund Flow, Thailand, 2016

Figure 11: Health Insurance Development, Thailand, 2016

Figure 12: Addition to National List of Essential Drugs, Thailand, 2016

Figure 13: Drug Procurement Process, Thailand, 2016

Figure 14: Health Benefits Coverage, Thailand, 2011

Figure 15: Market Access, Thailand, Patient Share of Total Health Expenditure (%), 2008-2015

Figure 16: Market Access, Thailand, Producer Price Change (%), 2008-2015

Figure 17: Food and Drug Administration, Thailand, Structure, 2016

Figure 18: Marketing Authorization Procedure, New Drugs, Thailand, 2016

Figure 19: Marketing Authorization Procedure, Generics, Thailand, 2016

Figure 20: Marketing Authorization Procedure, New Generic Drugs, Thailand, 2016

Figure 21: Import Licensing Process for General Medical Device, Thailand, 2016

Figure 22: Patent Approval Process, Thailand, 2016

Figure 23: Trademark Approval Process, Thailand, 2016

Figure 24: Clinical Trial Regulation Process, Thailand, 2016

Figure 25: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2008-2015

Figure 26: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2016-2020

Figure 27: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2008-2015

Figure 28: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2016-2020

Figure 29: Economic Indicators, Thailand, Gross National Income per Capita ($), 2008-2015

Figure 30: Economic Indicators, Thailand, Consumer Price Index, 2008-2015

Figure 31: Economic Indicators, Thailand, Consumer Price Index, 2016-2020

Figure 32: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2008-2015

Figure 33: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2016-2020

Figure 34: Economic Indicators, Thailand, Currency Exchange Rate (THB/$), 2008-2015

Figure 35: Economic Indicators, Thailand, Foreign Direct Investment ($bn), 2008-2014

Figure 36: Economic Indicators, Thailand, Foreign Exchange Reserves ($bn), 2008-2014

Figure 37: Economic Indicators, Thailand, Imports of Goods and Services ($bn), 2008-2014

Figure 38: Economic Indicators, Thailand, Exports of Goods and Services ($bn), 2008-2014

Figure 39: Economic Indicators, Thailand, Government Structural Balance ($bn), 2008-2015

Figure 40: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2008-2015

Figure 41: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2016-2020

Figure 42: Major Industries, Thailand, Share of GDP at Current Market Prices (%), 2014

Figure 43: Demographics, Thailand, Population (million), 2008-2015

Figure 44: Demographics, Thailand, Population (million), 2016-2020

Figure 45: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2008-2015

Figure 46: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2016-2020

Figure 47: Demographics, Thailand, Population Distribution (%), 2008-2015

Figure 48: Demographics, Thailand, Population Distribution (%), 2016-2020

Figure 49: Demographics, Thailand, Births (per 1,000 population), 2008-2015

Figure 50: Demographics, Thailand, Mortality (per 1,000 population), 2008-2015

Figure 51: Demographics, Major Causes of Mortality, Thailand, Share of Total Mortality (%), 2014

Figure 52: Demographics, Thailand, Children Under Five Years of Age, Infant Mortality (per 1,000 live births), 2008-2015

Figure 53: Demographics, Thailand, Immunization Rate (%), 2008-2015

Figure 54: Demographics, Thailand, Major Causes of Male Mortality (Share %), 2010

Figure 55: Demographics, Thailand, Major Causes of Female Mortality (Share %), 2010

Figure 56: Demographics, Thailand, Gender Ratio (M/F), 2008-2015

Figure 57: Demographics, Thailand, Life Expectancy at Birth (years), 2008-2015

Figure 58: Demographics, Thailand, Life Expectancy at Birth (Years), 2016-2020

Figure 59: Demographics, Thailand, Gross Enrolment Ratio (%), 2008-2015

Figure 60: Demographics, Thailand, Unemployment Rate (%), 2008-2015

Figure 61: Demographics, Thailand, Major Diseases, DALYs, 2012

Figure 62: Healthcare Infrastructure, Thailand, Hospitals, 2008-2015

Figure 63: Healthcare Infrastructure, Thailand, Public and Private Hospitals, 2008-2015

Figure 64: Healthcare Infrastructure, Thailand, Hospitals by Standard of Care, Share (%), 2010

Figure 65: Healthcare Infrastructure, Thailand, Hospital Beds by Authority and Region, Share (%), 2010

Figure 66: Healthcare Infrastructure, Thailand, Hospital Beds (per 1,000 population), 2008-2015

Figure 67: Healthcare Infrastructure, Thailand, Doctors (per 1,000 population), 2008-2015

Figure 68: Healthcare Infrastructure, Thailand, PM2.5 emissions (µgm/m³), 2008-2015

Figure 69: Healthcare Infrastructure, Thailand, CO2 Emissions (Metric Tons Per Capita), 2008-2015

Figure 70: Healthcare Infrastructure, Thailand, Dentists (per 100,000 population), 2008-2015

Figure 71: Healthcare Infrastructure, Thailand, Nurses (per 100,000 population), 2008-2015

Figure 72: Healthcare Infrastructure, Thailand, Pharmacists (per 100,000 population), 2008-2015

Figure 73: Healthcare Expenditure (% of GDP), Thailand, 2008-2015

Figure 74: Healthcare Expenditure, Thailand, Major Components of Healthcare Expenditure (%), 2012

Figure 75: Healthcare Expenditure, Thailand, Public and Private Shares of GDP (%), 2008-2015

Figure 76: Healthcare Expenditure, Thailand, R&D Expenditure (% of GDP), 2008-2015

Figure 77: Healthcare Market, Thailand, Opportunities and Challenges, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll